It is a pharma private limited company based in Chennai 600030, Tamil Nadu, India, established in 2005.
2005 | Chennai 600030, Tamil Nadu, India | ActiveBiomaarks Drugs India Private Limited, a active private limited company, was established on 19 August 2005 in Chennai 600030, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TN2005PTC057223. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.15 Cr and a paid-up capital of ₹9.82 M.
It upholds a compliant status. Its leadership includes Suresh Kumar (Director), Ravichandran Subbiah (Director), Muthusamy Soundaiyan (Managing Director). Past directors included Sankaralingapuram Malli Ketchani Ketchani Rajan, Lakshmi Narasimhan Mahadevan. It holds no open charges and ₹2.17 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.44, (Old No.13/4)East Club Road Shenoy Nagar, Chennai 600030, Tamil Nadu.
U24232TN2005PTC057223
057223
19 August 2005
₹1.15 Cr
₹9.82 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Biomaarks Drugs India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Kumar | Director | 19 Aug 2005 | Current |
| Ravichandran Subbiah | Director | 19 Aug 2005 | Current |
| Muthusamy Soundaiyan | Managing Director | 19 Aug 2005 | Current |
| Ketchaani Rajan Makesh | Director | 03 Sep 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2010 | Past |
| Pramod Abcsdd | Director | 17 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biomaarks Drugs India Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 14.29% decrease. The company also saw a substantial improvement in profitability, with a 99.66% increase in profit. The company's net worth dipped by a decrease of 5.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Biomaarks Drugs India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹21,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2006 | State Bank Of India | ₹2.17 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biomaarks Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biomaarks Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomaarks Drugs India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Biomaarks Drugs India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Biomaarks Drugs India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge registered on 12 Jan 2006 via Charge ID 90291057 with State Bank Of India was fully satisfied on 19 Apr 2013. was completed.
The activity Ketchaani Rajan Makesh was appointed as a Director was appointed as a Director on 03 Sep 2010 & has been associated with this company since 15 years 4 months . was completed.
Progress on A charge with State Bank Of India of Rs. 2.17 Cr registered on 12 Jan 2006 with Charge ID 90291057 was modified on 04 Feb 2009. was documented.
The activity A charge with State Bank Of India amounted to Rs. 2.17 Cr with Charge ID 90291057 was registered on 12 Jan 2006. was completed.
The CIN of Biomaarks Drugs India Private Limited is U24232TN2005PTC057223.
Biomaarks Drugs India Private Limited is headquartered at No.44, (Old No.13/4)East Club Road Shenoy Nagar, Chennai 600030, Tamil Nadu.
Biomaarks Drugs India Private Limited was incorporated on 19 August 2005.
The current directors of Biomaarks Drugs India Private Limited are
The primary industry of Biomaarks Drugs India Private Limited is Manufacturing.
Biomaarks Drugs India Private Limited is unlisted.
The authorized capital of Biomaarks Drugs India Private Limited is ₹1.15 Cr, and the paid-up capital is ₹9.82 M.
The compliance status of Biomaarks Drugs India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX